NCT05486832
Safety and Performance of the Cardiovalve TR Replacement System
Safety and Performance of the Cardiovalve TR Replacement System for Tricuspid Regurgitation
Cardiovalve Ltd.·ClinicalTrials.gov·device·Device trialRecruiting
View on ClinicalTrials.gov →Study focus
- Disease/Condition
- Tricuspid Regurgitation
- Drug/Device/Intervention
- Cardiovalve TR valve replacement System
- Study type
- Interventional
- Intervention type
- device
Sponsor & location
- Primary sponsor
- Cardiovalve Ltd.
- Location
- Bad Oeynhausen,Berlin,Bonn,Hamburg,Köln,Lübeck,Regensburg, Germany
Timeline & enrollment
- Phase
- N/A
- Start date
- Aug 15, 2022
- End date
- Dec 15, 2026
- Enrollment
- 100 participants
Primary outcome
Freedom from device or procedure-related adverse events,Reduction in TR grade
Summary
The objective of this study is to evaluate the safety and performance of Cardiovalve TR
 system
ICD-10 classifications
Tricuspid stenosisTricuspid stenosis with insufficiencyNonrheumatic tricuspid (valve) stenosisTricuspid insufficiencyNonrheumatic tricuspid (valve) stenosis with insufficiency
Data source
- Registry
- ClinicalTrials.gov
- Trial ID
- NCT05486832
- Type
- Device Trial
About this record
Access comprehensive clinical trial information for NCT05486832 through Pure Global AI's free database. This phase not specified trial is sponsored by Cardiovalve Ltd. and is currently Recruiting. The study focuses on Tricuspid Regurgitation. Target enrollment is 100 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.